Amadeus Integrates IBM Digital Health Pass Into Its Digital Health Verification Technology

IBMIBM (NYSE: IBM) and Amadeus (MCE: AMS) announced that they are working together to help meet one of the major challenges facing travel companies today: checking and validating the COVID-19 health documentation of travelers at checkpoints where required.

As part of that effort, IBM Digital Health Pass is now integrated into Traveler ID for Safe Travel, Amadeus' digital health verification solution. This enables airlines to integrate the use of COVID-19 digital health credentials into their existing reservation and booking system, allowing airline passengers the option to scan or upload documentation to show their health credentials.

As passengers move through the online check-in process, Traveler ID for Safe Travel checks the requirements for that particular trip against destination country regulations. This then prompts passengers with the option to generate a secure COVID-19 digital credential by scanning paper documents or uploading a digital version from their mobile or desktop.

These COVID-19 digital health credentials are then verified using IBM Digital Health Pass, which uses a combination of encryption and blockchain technologies to authenticate COVID-19 health credentials against a global ecosystem of labs, vaccination centers and healthcare providers. Airlines receive a simple status confirming a passenger is ready to fly. This secure approach provides passenger privacy since only the compliance with border entry requirements is confirmed; no personal health information is stored by the airline, IBM, or Amadeus.

"While countries across the globe are beginning to slowly reopen borders to welcome back visitors, specific border entry requirements may vary greatly country to country. The need to check COVID-19 health documentation is causing significant delays during the journey for airlines and other travel providers, as well as the traveler," said Greg Land, Travel and Transportation Industry Lead, IBM. "The integration of IBM Digital Health Pass into Amadeus' Traveler ID for Safe Travel is designed to provide airlines with open technologies they can build into existing digital solutions. This can help airlines safely meet border entry requirements while delivering a smoother customer experience."

"The integration with IBM is a step-change for Traveler ID for Safe Travel. The combination of the IBM Digital Health Pass with our Traveler ID for Safe Travel technology means that COVID-19 health documents can be digitized and read, verified, and authenticated. This avoids cumbersome and time-consuming checks while traveling, and adds further reassurance to airlines and their passengers," said Christian Warneck, VP Safe Travel Ecosystem, Amadeus. "This is another milestone in the collaboration we are driving through our Safe Travel Ecosystem. By working hand in hand with customers and partners such as IBM, we can deliver the capabilities needed by travel providers and travelers to help provide a smooth passenger journey once more."

Traveler ID for Safe Travel is currently live with multiple airlines, with additional airline customers to be announced soon. Traveler ID's digital identity and health verification capabilities are also relevant for other customer groups, including hotels and airports.

About IBM

For more information about IBM visit, www.ibm.com.

About Amadeus

Travel powers progress. Amadeus powers travel. Amadeus' solutions connect travelers to the journeys they want through travel agents, search engines, tour operators, airlines, airports, hotels, cars and railways. We have developed our technology in partnership with the travel industry for over 30 years. We combine a deep understanding of how people travel with the ability to design and deliver the most complex, trusted, critical systems our customers need. We help connect over 1.6 billion people a year to local travel providers in over 190 countries. We are one company, with a global mindset and a local presence wherever our customers need us. Our purpose is to shape the future of travel. We are passionate in our pursuit of better technology that makes better journeys.

Amadeus is an IBEX 35 company, listed on the Spanish Stock Exchange under AMS.MC. The company is also part of the EuroStoxx50 and has been recognized by the Dow Jones Sustainability Index for the last eight years.

To find out more about Amadeus, visit www.amadeus.com.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...